BREANNA SHENK: Open Payments
NPI 1659051621 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,026 in 87 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $3,248 · 2025 $3,026
Food & beverage: $2,015Travel & lodging: $1,011
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 13 | $1,527 |
| Novo Nordisk Inc | 21 | $303 |
| Xeris Pharmaceuticals, Inc. | 13 | $249 |
| Sequel Med Tech, LLC | 9 | $214 |
| SANOFI-AVENTIS U.S. LLC | 6 | $192 |
| Dexcom, Inc. | 8 | $187 |
| Corcept Therapeutics | 4 | $80 |
| Averitas Pharma Inc. | 1 | $40 |
| Insulet Corporation | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
Products named: MINIMED 780G, Ozempic, GVOKE HYPOPEN, TWIIST, TZIELD, Dexcom G6 Transmitter, Korlym, Wegovy.
Industry payments across MS — which companies pay providers there.
